Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

Abstract The continuous emergence of SARS-CoV-2 variants of concern has rendered many therapeutic monoclonal antibodies (mAbs) ineffective. To date, there are no clinically authorized therapeutic antibodies effective against the recently circulating Omicron sub-lineages BA.2.86 and JN.1. Here, we re...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Communications Biology
المؤلفون الرئيسيون: Melanie R. Walker, Alexander Underwood, Kasper H. Björnsson, Sai Sundar Rajan Raghavan, Maria R. Bassi, Alekxander Binderup, Long V. Pham, Santseharay Ramirez, Mette Pinholt, Robert Dagil, Anne S. Knudsen, Manja Idorn, Max Soegaard, Kaituo Wang, Andrew B. Ward, Ali Salanti, Jens Bukh, Lea Barfod
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Nature Portfolio 2024-10-01
الوصول للمادة أونلاين:https://doi.org/10.1038/s42003-024-06951-7

الانترنت

https://doi.org/10.1038/s42003-024-06951-7

مواد مشابهة